amikacin has been researched along with vancomycin in 243 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (9.88) | 18.7374 |
| 1990's | 52 (21.40) | 18.2507 |
| 2000's | 72 (29.63) | 29.6817 |
| 2010's | 77 (31.69) | 24.3611 |
| 2020's | 18 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Giles, D; Keshavayya, J; Mathew, V; Vaidya, VP | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Chang, CW; Chiang, FI; Czyryca, PG; Li, D; Wu, L; Zhang, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chan, KY; Chang, CW; Litke, AP; Redman, N; Zeng, J; Zhan, J; Zhang, J | 1 |
| Abraham, R; Basavarajaswamy, G; Giles, D; Mathew, V; Sandhya, B | 1 |
| Herdewijn, P; Maiti, M; Nauwelaerts, K | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
| Chang, CW; Takemoto, JY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
| Baker, C; Chang, CT; Kawasaki, Y; Shrestha, JP; Subedi, YP; Takemoto, JY; Vincent de Paul, NN | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
| He, Y; Hu, Z; Huang, J; Li, Q; Li, XN; Liu, J; Wang, J; Xue, Y; Zhang, Y; Zhu, H | 1 |
| Arya, G; Dalal, P; Kaur, M; Nimesh, S; Salunke, DB; Singh, R; Singla, P | 1 |
| Dou, X; Feng, X; He, S; Shan, A; Song, J; Wang, J; Yang, Y; Yang, Z | 1 |
| Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Chen, X; Hu, Y; Hu, Z; Li, F; Li, H; Lin, S; Wang, J; Yang, B; Yu, H; Zhang, S; Zhang, Y | 1 |
| Alexandrova, LA; Avdanina, DA; Boykova, YV; Efimenko, TA; Efremenkova, OV; Glukhova, AA; Jasko, MV; Karpenko, IL; Kochetkov, SN; Kolonitskaya, DP; Kost, NV; Negrya, SD; Nuraeva, GK; Shevchenko, OV; Solodinin, AP; Solyev, PN; Volkov, IA; Zhgun, AA | 1 |
| Granatek, AP; Nunning, BC; Ricci, RA | 1 |
| Long, CI; Vannatta, JB | 1 |
| Hanberger, H | 1 |
| Cars, O; Löwdin, E; Odenholt-Tornqvist, I | 1 |
| Altay, G; Cokça, F | 1 |
| Trese, MT; Winkler, BS | 1 |
| Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P | 1 |
| Bosseray, A; Brion, JP; Hollard, D; Michallet, M; Micoud, M; Nicolini, F; Stahl, JP | 1 |
| D'Amico, DJ; Kwak, HW; Oum, BS; Wong, KW | 1 |
| Kuechle, DK; Landon, GC; Musher, DM; Noble, PC | 1 |
| Aoun, M; Ibrahim, S; Meunier, F; Tulkens, PM; Van der Auwera, P | 1 |
| Calubiran, OV; Cunha, BA; Schoch, PE | 1 |
| Bodey, GP; Ho, DH; Rolston, K | 1 |
| Van der Auwera, P | 1 |
| Crotchett, J; Fischer, RP; Miller-Crotchett, P; Reed, RL; Wu, AH | 1 |
| Baker, CJ; Kaplan, SL; Mason, EO; Parisi, JT; Patrick, CC | 1 |
| Baker, DK; Goren, MP; Shenep, JL | 1 |
| D'Amico, DJ; Oum, BS; Wong, KW | 1 |
| Klastersky, J; Van der Auwera, P | 1 |
| Brion, JP; Bru, JP; Corron, B; Fauconnier, J; Michallet, M | 1 |
| Ajchenbaum, F; Baume, D; Chiche, D; Delmer, A; Fitoussi, F; Marie, JP; Pico, JL; Richet, H; Rio, B; Tancrède, C | 1 |
| Baker, DK; Blankenship, KR; Feldman, S; Gigliotti, F; Hughes, WT; Meyer, WH; Roberson, PK; Santana, VM; Shenep, JL; Sixbey, JW | 1 |
| Baltch, AL; Bassey, C; Fanciullo, G; Smith, RP | 1 |
| Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
| Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
| Gary, LB; Hall, JW; Herndon, DN; Winkler, JB | 1 |
| Lin, TY; McCracken, GH; Olsen, K; Sato, K; Weintrub, L | 1 |
| Cafferkey, MT; Hone, R; Keane, CT | 1 |
| Borges, LF; Chapman, PH | 1 |
| Babany, G; Benhamou, JP; Bernuau, J; Danan, G; Degott, C; Pessayre, D; Rueff, B; Trunet, P | 1 |
| Bouvet, A; Carbon, C; Contrepois, A; Cremieux, AC; Lamesch, C; Vallois, JM | 1 |
| Faurisson, F; Garaud, JJ; Regnier, B; Wolff, M | 1 |
| Aznar, J; García Iglesias, MC; Perea, EJ | 1 |
| Guerit, JM; Herbay, S; Houben-Giurgea, S; Mahieu, P | 1 |
| Carbon, C; Cochereau, I; Marrakchi-Benjaafar, S; Pocidalo, JJ | 1 |
| Meani, E; Romanõ, C | 1 |
| Bucaneve, G; Buelli, M; Carotenuto, M; D'Antonio, D; Gentile, G; Liso, V; Martino, P; Menichetti, F; Nosari, AM; Ricci, P | 1 |
| Dawidex, GM; Habib, NE; Headon, MP; Malik, TY; Price, NJ | 1 |
| Barbaut, X; Brazier, JL; Chuzeville, M; Confesson, MA; el Brouzi, M; Ivanoff, N; Jelliffe, RW; Maire, P; Pivot, C; Vergnaud, JM | 1 |
| Pascual, A; Perea, EJ; Ramirez de Arellano, E | 1 |
| Branchereau, A; Magnan, PE; Raoult, D; Seyral, P | 1 |
| Artiges, V; Bouffet, E; Bouhour, D; Brunat Mentigny, M; Charra, C; Couillioud, D; Frappaz, D; Fuhrmann, C | 1 |
| Bouquet, S; Courtois, P; Fauconneau, B; Ingrand, P; Pariat, C; Piriou, A | 1 |
| Can, G; Coban, A; Ince, Z; Ozgeneci, A; Uçsel, R | 1 |
| Stern, GA | 1 |
| Klastersky, J | 1 |
| Goetz, MB; Sayers, J | 1 |
| Berlin, OG; Bruckner, DA; Helm, CJ; Holland, GN; Lin, R | 1 |
| Andremont, A; Chiche, D; Guiguet, M; Hayat, M; Lagrange, P; Lapierre, V; Marie, JP; Pico, JL; Richet, H; Tancrede, C | 1 |
| Jacoby, GA | 1 |
| Kaplan, SL; Mason, EO; Ou, CN; Tan, TQ | 1 |
| Garbincius, J; Jandreski, MA | 1 |
| Aristimuño, B; Hemady, RK; Nirankari, VS; Rodrigues, MM | 1 |
| Benne, CA; Bruin, M; de Hoog, GS; Fleer, A; Neeleman, C | 1 |
| Daghistani, D; Horn, M; Rodriguez, Z; Schoenike, S; Toledano, S | 1 |
| Bourquelot, P; Bouscary, D; Dreyfus, F; Paul, G; Picard, F; Tulliez, M; Varet, B | 1 |
| Chobaz, C; Grounauer, PA; Piguet, B | 1 |
| Aulagner, G; Barbé, G; Bertrand, Y; Bréant, V; Dürr, F; Nakache, C; Vray, C | 1 |
| Hanberger, H; Nilsson, LE; Svensson, E | 1 |
| Lai, MY; Lim, WW; Lo, JY; Tam, BK | 1 |
| Holt, HA; MacGowan, AP; Reeves, DS; White, LO | 1 |
| Barbiery, P; Courcol, RJ; Roussel-Delvallez, M; Wallet, F | 1 |
| Cetinkaya, O; Eray Bulut, H; Günay, Y; Onarlioglu, B; Törel Ergür, A | 1 |
| Hykin, P; Lightman, S; Matheson, M; Okhravi, N; Towler, HM | 1 |
| Chankova, D; Guirguitzova, B; Minkov, N; Zozikov, B | 1 |
| Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A | 1 |
| Berneman, ZN; Bruyneel, P; Goossens, H; Mebis, J; Meeus, I; Schroyens, W; Sion, JP; Van Droogenbroeck, J | 1 |
| Barbé, G; Bertrand, Y; Philippe, N; Ploton, C; Pondarré, C; Souillet, G | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P | 1 |
| Arsieri, R; Pugliese, A; Vicedomini, D; Zappelli, S | 1 |
| Lovering, AM; MacGowan, AP; White, LO | 1 |
| Dart, JK; Horgan, SE; Matheson, MM; McLOUGHLIN-Borlace, L | 1 |
| Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi-Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
| Benson, WE; Brown, GC; Regillo, CD; Shah, GK; Sharma, S; Sivalingam, A; Stein, JD; Tasman, W | 1 |
| Jelliffe, R; Schumitzky, A; Van Guilder, M | 1 |
| Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I | 1 |
| Bandera, A; Degli Esposti, A; Ferrario, G; Franzetti, F; Gori, A; Marchetti, G; Rossi, MC; Tocalli, L | 1 |
| Barberi-Heyob, M; Chastagner, P; Lascombes, P; Lozniewski, A; Merlin, JL; Merthes, PM | 1 |
| Kim, CY; Koh, HJ; Kwon, OW | 1 |
| Gadba, R; Ofir, O; Samra, Z | 1 |
| Abreu, A; Barry, P; Cordovés, L; Seal, D | 1 |
| Landau, M; Nucci, M; Pulcheri, W; Silveira, F; Spector, N | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
| Jin, D; Wu, H; Wu, Z; Xu, J | 1 |
| Baranger, B; Brinquin, L; Fangio, P; Petitjeans, F; Rouquette-Vincenti, I; Szymczyszyn, P; Villevieille, T | 1 |
| Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L | 1 |
| Acartürk, E; Akgül, F; Paydaş, S | 1 |
| Lankford, MG; Noskin, GA; Peterson, LR; Suntharam, N; Trick, WE | 1 |
| de André Júnior, LS; de Resende, MV; Schmidt, ML; Vieira, ML | 1 |
| Hanssen, AD; Khaliq, Y; Osmon, DR; Patel, R; Perry, AC; Piper, KE; Rouse, MS; Steckelberg, JM | 1 |
| Elder, MJ; Morlet, N | 1 |
| Hermida, J; Tutor, JC; Zaera, S | 1 |
| Hesse, Y; Lang, GK; Spraul, CW | 1 |
| Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A | 1 |
| Caorlin, MJ; Carvajal, L; Cuello, OH; Juarez, CP; Luna, JD; Palacio de Guerra, E; Reviglio, VE | 1 |
| Claude, D; Corvaisier, S; Ducher, M; Jelliffe, R; Maire, P; Maurin, M; Rougier, F; Sedoglavic, A | 1 |
| Subramanian, ML; Topping, TM | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Matoba, AY | 1 |
| Al Hammadi, AY; El Desoky, ES; Sheikh, AA | 1 |
| Xiang, XD; Yang, H; Yi, ZM | 1 |
| Engelbert, M; Grasbon, T; Kampik, A; Klauss, V; Miño de Kaspar, H; Schulze-Schwering, M; Ta, CN; Thiel, M | 1 |
| Akgül, H; Bornfeld, N; Brockmann, C; Höck, K; Laube, T; Schilling, H; Schüler, A | 1 |
| Avila-Agüero, ML; Huertas, E; Ulloa-Gutierrez, R | 1 |
| Dou, Y; Liao, ZJ; Zhang, Q | 1 |
| Cernohorská, L; Votava, M | 1 |
| Lam, CS; Lee, HK; Leung, KT; Ng, HL; Siu, YP; Tong, MK | 1 |
| Ahmed, U; Burney, IA; Khan, MA; Shamim, A; Siddiqui, BK; Yosuf, MA; Zakiullah, N | 1 |
| Al-Qasabi, SS; Nzeako, BC | 1 |
| Au Eong, KG; Chee, CK; Lee, JJ; Teoh, SC | 1 |
| Iyer, MN; Kim, SH; Simons, KB; Wirostko, WJ | 1 |
| Jeyaratnam, D; Keenan, N; Sheerin, NS | 1 |
| Aguado, JM; Colomer, R; Cortés-Funes, H; López-Martín, A; López-Medrano, F; Lumbreras, C; Rodríguez, FJ; Sánchez-Muñoz, A | 1 |
| Fu, YL; Lin, JM; Tsai, YY | 1 |
| Cheung, PY; Etches, PC; Peliowski, A; Robertson, CM; Tyebkhan, JM | 1 |
| Chong, Y; Ha, GY; Jeong, SH; Lee, K; Lim, HS; Park, KH; Shin, JH; Yong, D | 1 |
| Chan, RC; Cheung, SW; Hui, M; Kwok, AK; Lam, DS; Pang, CP | 1 |
| Almirante, B; Calleja, R; Fernandez-Hidalgo, N; Pahissa, A; Pigrau, C; Planes, AM; Rodriguez, D; Ruiz, I | 1 |
| Helbig, H; Widmer, S | 1 |
| Hermida, J; Tutor, JC | 1 |
| Bonetto, M; Carli, M; Cavaliere, M; Cesaro, S; Gavin, P; Magagna, L; Rossi, L; Spiller, M | 1 |
| Ghalib, MB; Hassan, IS | 1 |
| Leaños-Miranda, BE; Miranda-Novales, G; Solórzano-Santos, F; Vilchis-Pérez, M | 1 |
| Allegaert, K; Anderson, BJ; Rayyan, M | 1 |
| Bejjani, RA; Dighiero, P; Ellies, P; Gicquel, JJ; Mercié, M | 1 |
| Allegaert, K; Anderson, BJ; de Zegher, F; van den Anker, JN; Vanhaesebrouck, S | 1 |
| Ruggieri-Marone, M; Schochat, E | 1 |
| De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L | 1 |
| Albessard, F; Chédru-Legros, V; Chérel, A; Debruyne, D; Fines-Guyon, M; Mouriaux, F; Perdriel, A | 2 |
| Chen, WL; Chiang, CC; Chiu, YT; Lin, JM; Tsai, YY | 1 |
| Berrocal, A; Flynn, HW; Miller, D; Miller, JJ; Murray, TG; Scott, IU; Smiddy, WE | 1 |
| De Kaspar, HM; Engelbert, M; Kampik, A; Mette, M; Ta, CN; Thiel, M | 1 |
| Butler, L; Durrani, OM; Konstantinos, C; Mollan, AJ; Mollan, SP | 1 |
| Doft, BH | 1 |
| Hua, R; Rong, XZ; Yang, RH; Zhang, T | 1 |
| Kau, YC; Liaw, CW; Liu, SJ; Peng, YJ | 1 |
| Chen, KJ; Sun, CC; Yang, KJ; Yeung, L | 1 |
| Aksoy, A; Bahat, E; Cakir, M; Dilber, B; Dilber, E; Kamaşak, T | 1 |
| Allegaert, K | 1 |
| Atapour, AA; Beigi, AA; Eshaghian, A; Khademi, EF; Khansoltani, S; Masoudpour, H | 1 |
| Kau, YC; Liu, KS; Liu, SJ; Peng, YJ; Wen, CW | 1 |
| Kocyigit, I; Oymak, O; Sipahioglu, MH; Somdas, MA; Tokgoz, B; Ucar, C; Unal, A; Utas, C | 1 |
| Bumgardner, JD; Courtney, HS; Haggard, WO; Noel, SP | 1 |
| Das, A; Ray, P; Sharma, M; Singh, R | 1 |
| Bratt, GW; Dille, MF; Fausti, SA; Gallun, F; Gordon, JS; Helt, WJ; Konrad-Martin, D; Reavis, KM | 1 |
| Atilla, A; Boothe, DM; Boothe, HW; Diaz, DC; Duran, S; Sofge, J; Tollett, M | 1 |
| Haggard, WO; Noel, SP; Stinner, DJ; Watson, JT; Wenke, JC | 1 |
| Higashi, M; Iwasaka, T; Kakimoto, S; Kido, E; Morimoto, S; Morita, T; Someya, K; Sumitani, N; Suzuki, K; Takagishi, H; Yasui, A | 1 |
| Ales, M; Bove, F; Cudillo, L; Cupelli, L; Dentamaro, T; Fabritiis, Pd; Falco, S; Giovannini, M; Mirabile, M; Niscola, P; Picardi, A; Scaramucci, L; Spagnoli, A; Tendas, A | 1 |
| Das, T; Joseph, J; Pathengay, A; Sachdeva, V; Sharma, S | 1 |
| Balada-Llasat, JM; Buckosh, M; Hemminger, J; Pancholi, P; Raczkowski, M | 1 |
| Kocyigit, I; Oymak, O; Sipahioglu, M; Somdas, M; Tokgoz, B; Ucar, C; Unal, A; Utas, C; Vural, A | 1 |
| Abrishami, M; Gharaee, H; Khalife, M; Poor, SS | 1 |
| Bizikova, T; Minihan, AC; Thomas, LA | 1 |
| Fujita, T; Hanafusa, N; Hisaka, A; Katada, S; Noiri, E; Suzuki, H; Yahagi, N; Yamamoto, T; Yasuno, N | 1 |
| Barretti, P; Caramori, JC; Cunha, Mde L; Luengo, J; Montelli, AC; Oliveira, LG | 1 |
| Barrett, JG; Brown, JA; Hart, SK; Papich, MG; Powers, BE; Sullins, KE | 1 |
| Chlebicki, MP; Heng, WL; Lee, WH; Lim, CH; Lim, YP; Seck, T; Tan, BH | 1 |
| Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
| Bělohlávek, J; Bouček, T; Fichtl, J; Hodková, G; Huptych, M; Kittnar, O; Linhart, A; Mlček, M; Mrázek, V; Springer, D; Zima, T | 1 |
| Bowler, IC; Collier, J; Colston, JM; Scarborough, M | 1 |
| Courtney, HS; Haggard, WO; Jennings, JA; Moshref, AR; Smith, JK | 1 |
| Basu, S; Das, TP; Kar, S; Mohan, N; Padhi, TR; Sharma, S | 1 |
| Inoue, Y; Kishi, K; Ochiai, H; Ohsugi, I; Sakamoto, Y; Yoshimura, Y | 1 |
| Healy, D; Kagan, R; Neely, A; Sherwin, CM; Spigarelli, MG; Stockmann, C; Wead, S | 1 |
| Biran, V; Jacqz-Aigrain, E; Zhao, W | 1 |
| Dollin, M; Garg, SJ; Hsu, J; Pitcher, J; Reddy, S; Storey, P; Vander, J; Vojtko, J | 1 |
| Arora, D; Fysal, N; Hafiz, KA; Jose, S; Kulshrestha, R; Vasudevan, S | 1 |
| Albini, TA; Berrocal, AM; Flynn, HW; Kuriyan, AE; Miller, D; Smiddy, WE; Weiss, KD | 1 |
| Ben Reguiga, M; Sayet, G; Sinegre, M | 1 |
| Bijleveld, Y; Cools, F; de Haan, TR; de Jonge, R; Dijk, P; Dijkman, KP; Gavilanes, AWD; Groenendaal, F; Jorjani, S; Mathôt, R; Nuytemans, D; Rijken, M; Toersche, J; van der Lee, J; van Heijst, A; van Straaten, H; Zonnenberg, I | 1 |
| Bowler, IC; Gupta, A; Hornby, SJ; Orlans, HO | 1 |
| Conejo, MC; Domínguez, MC; Pascual, Á; Rodríguez-Baño, J; Vergara-López, S | 1 |
| Beenken, KE; Carpenter, DP; Courtney, HS; Haggard, WO; Jennings, JA; Smeltzer, MS; Troxel, KS | 1 |
| Beloin, C; Ghigo, JM; Lebeaux, D; Leflon-Guibout, V | 1 |
| Agraharam, D; Chandra Mohan, AK; Jayaramaraju, D; Kulkarni, S; Perumal, R; Shanmuganathan, R | 1 |
| Amemoto, Y; Aoyama, T; Arakawa, S; Deguchi, T; Egawa, S; Fujimoto, Y; Fujisawa, M; Goto, H; Hamasuna, R; Hanaki, H; Hashimura, T; Hayami, H; Hirose, T; Ichikawa, T; Inatomi, H; Ishihara, S; Ishikawa, K; Ishitoya, S; Ito, N; Ito, T; Iwata, S; Kadota, J; Kagara, I; Kaku, M; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Kobuke, M; Koda, S; Komeda, H; Kumon, H; Kunishima, Y; Maeda, H; Matsubara, A; Matsuda, Y; Matsui, T; Matsukawa, M; Matsumoto, M; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Muranaka, T; Nakamura, I; Nishimura, K; Oka, H; Okumura, K; Onishi, H; Onodera, S; Sato, J; Shigeta, M; Sunakawa, K; Taguchi, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Togo, Y; Tsugawa, M; Tsukamoto, T; Uehara, S; Wakeda, H; Watanabe, A; Yamada, D; Yamamoto, S; Yamashita, M; Yasuda, M | 1 |
| Dollin, M; Fang-Yen, NH; Garg, SJ; Hsu, J; Pitcher, JD; Storey, P; Vander, J | 1 |
| Fili, S; Hayvazov, S; Kohlhaas, M; Kontopoulou, K; Schilde, T | 1 |
| Beenken, KE; Courtney, HS; Haggard, WO; Jennings, JA; Parker, AC; Smeltzer, MS; Smith, JK | 1 |
| Chaudhry, T; Gilson, A; Gollogly, J; Kennedy, K; Mony, K; Noor, S; Swanson, A; Vanny, V | 1 |
| Flynn, HW; Huang, LC; Kuriyan, AE; Leung, EH; Miller, D | 1 |
| Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
| Alonso-Isa, M; Benítez-Sala, R; García-Rojo, E; Gil-Moradillo, J; González-Padilla, DA; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Passas-Martínez, JB; Sopeña-Sutil, R; Tejido-Sánchez, Á | 1 |
| Koch, G; Pfister, M; Schropp, J | 1 |
| Alexandropoulos, P; Chantziara, V; Chinou, E; Georgiou, S; Lagiou, F; Micha, G; Michaloudis, G; Tsimogianni, A; Vassi, A | 1 |
| Carroll, K; Cohen, DM; Cross, CP; Feeney, MP; Garinis, AC; Gold, JA; Hunter, LL; Keefe, DH; Putterman, DB; Srikanth, P; Steyger, PS | 1 |
| Burmistrova, DS; D'yakonova, IN; Ishanova, YS; Kamkina, OV; Rakhmanova, IV | 1 |
| Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N | 1 |
| Barberini, L; Carotti, A; di Michele, A; Giovagnoli, S; Pietrella, D; Ricci, M; Santi, C | 1 |
| Daniher, D; Kadrichu, N | 1 |
| Awais, R; Beenken, KE; Boles, LR; Haggard, WO; Jessica, AJ; Smeltzer, MS | 1 |
| Decousser, JW; Dowzicky, MJ; Fines-Guyon, M; Soussy, CJ; Woerther, PL | 1 |
| Cui, FQ; Dai, B; Fu, JD; Guan, F; Hu, ZQ; Huang, H; Li, YB; Mao, BB; Peng, WC; Ren, ZY; Wang, ZY; Xiao, ZY; Zhu, GT | 1 |
| Bousquet-Melou, A; Broussou, DC; El Garch, F; Ferran, AA; Toutain, PL; Woehrlé, F | 1 |
| Boles, LR; Bumgardner, JD; Fujiwara, T; Guerra, FD; Haggard, WO; Jennings, JA | 1 |
| Antunes, MV; Bastiani, MF; Brucker, N; da Silva, ACC; de Lima Feltraco Lizot, L; Linden, R | 1 |
| Chan, JW; Chua, JM; Chua, WBB; Lee, Q; Lim, WXS; Poh, BH; Sultana, R | 1 |
| Brown, MN; Haggard, WO; Harrison, ZL; Jennings, JA; Pace, LR | 1 |
| Batra, S; Biswas, P; Chatterjee, S; Ginodia, A | 1 |
| Charlier, C; Dubois, N; Gilson, M; Sqalli, G | 1 |
| Calvo, MV; Lanao, JM; Martín-Suárez, A; Pérez-Blanco, JS; Sáez Fernández, EM | 1 |
| Allegaert, K; Smits, A; van den Anker, J; van Donge, T | 1 |
| Greisen, G; Gupta, M; Jakobsen, JC; Korang, SK; Lausten-Thomsen, U; Nava, C; Safi, S | 1 |
| Bostrom, MP; Carli, AV; Driscoll, DA; Levack, AE; Miller, AO; Turajane, K; Wellman, DS; Yang, X | 1 |
| Alloux, C; Bourguignon, L; Goutelle, S; Maire, P; Neely, M; Van Guilder, M | 1 |
| Chen, HC; Chen, KJ; Chen, YP; Chou, HD; Hou, CH; Kang, EY; Lai, CC; Liu, L; Sun, MH; Wang, NK; Wu, WC | 1 |
| Chávez M, P; Delpiano M, L; Fernández H, A; Hernández M, R | 1 |
| Al Ansari, E; Al Jufairi, M; Al Madhoob, A; Al Marzooq, R; Al Segai, O; Hashem Ahmed, H; Husain Shaban, G; Malalla, Z; Saeed Tabbara, K; Sridharan, K | 1 |
| Ahmad, S; Ahmed, S; Ali, F; Farooq, M; Haq, I; Qureshi, SA; Rasheed, A; Sabir, MS; Shakeela, Q; Uzma, B | 1 |
| De Vito, D; Fruscio, G; Garrisi, VM; Hall, GG; Laforgia, M; Nardulli, P; Quarta, A; Ruggiero, R; Scacco, S | 1 |
| Abdul Ameer Al-Kraety, I; Ghani Al-Muhanna, S; Maki N Al-Muaala, A; Sadeq Yasir Al-Ethari, A | 1 |
| Habib, A; Qadir, A | 1 |
| Jia, L; Jiang, Y; Li, X; Peng, Z; Wang, Y | 1 |
| Bouscary, D; Canouï, E; Charlier, C; Contejean, A; Fantin, B; Garcia-Vidal, C; Kernéis, S; Maillard, A; Parize, P | 1 |
12 review(s) available for amikacin and vancomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pseudomonas paucimobilis bacteraemia associated with haemodialysis.
Topics: Aged; Aged, 80 and over; Amikacin; Humans; Male; Pseudomonas Infections; Renal Dialysis; Vancomycin | 1990 |
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin | 1989 |
Shunt infections: prevention and treatment.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Injections, Intravenous; Injections, Intraventricular; Klebsiella Infections; Leukocytes; Meningitis; Premedication; Pseudomonas Infections; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 1985 |
Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.
Topics: Amikacin; Animals; Dexamethasone; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Male; Postoperative Complications; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Tissue Plasminogen Activator; Vancomycin | 1993 |
Febrile neutropenia.
Topics: Amikacin; Amphotericin B; Bacteremia; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Mycoses; Neoplasms; Neutropenia; Vancomycin; Virus Diseases | 1993 |
Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination.
Topics: Aged; Aged, 80 and over; Amikacin; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Vancomycin | 1993 |
Infectious complications in bone marrow transplantation. Resistant bacterial infections.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Humans; Lactams; Vancomycin | 1993 |
Fulminant Listeria monocytogenes meningitis complicated with acute hydrocephalus in healthy children beyond the newborn period.
Topics: Acute Disease; Amikacin; Cefotaxime; Child; Child, Preschool; Combined Modality Therapy; Costa Rica; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Emergencies; Fatal Outcome; Female; Humans; Hydrocephalus; Male; Meningitis, Listeria; Meropenem; Rifampin; Thienamycins; Tomography, X-Ray Computed; Vancomycin; Ventriculostomy | 2004 |
Recurrent Enterococcus faecalis endophthalmitis after phacoemulsification.
Topics: Amikacin; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Recurrence; Vancomycin; Vitrectomy | 2005 |
Antibiotic regimens for late-onset neonatal sepsis.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bias; Cefazolin; Clavulanic Acid; Drug Therapy, Combination; Floxacillin; Gentamicins; Humans; Infant, Newborn; Neonatal Sepsis; Randomized Controlled Trials as Topic; Ticarcillin; Vancomycin | 2021 |
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Febrile Neutropenia; Hematologic Neoplasms; Humans; Vancomycin | 2023 |
27 trial(s) available for amikacin and vancomycin
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin | 1992 |
[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Vancomycin | 1992 |
Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer In
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Positive Bacteria; Humans; Infant; Male; Middle Aged; Neoplasms; Prospective Studies; Sepsis; Vancomycin | 1991 |
Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Corynebacterium; Daptomycin; Drug Therapy, Combination; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1989 |
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin | 1989 |
Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously.
Topics: Amikacin; Anti-Bacterial Agents; Corynebacterium; Drug Interactions; Glycopeptides; Gram-Positive Bacteria; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Nontuberculous Mycobacteria; Random Allocation; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1987 |
[Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillins; Prospective Studies; Ticarcillin; Vancomycin | 1988 |
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Neutropenia; Random Allocation; Vancomycin | 1988 |
Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillins; Random Allocation; Ticarcillin; Vancomycin | 1988 |
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Topics: Adolescent; Adult; Aged; Amikacin; Amphotericin B; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Teicoplanin; Vancomycin | 1994 |
Once daily antibiotic regimen in paediatric oncology.
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Humans; Infant; Neoplasms; Teicoplanin; Vancomycin | 1994 |
Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Vancomycin | 1993 |
Prevention of indwelling central venous catheter sepsis.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Heparin; Humans; Incidence; Infant; Infection Control; Inservice Training; Male; Medical Staff, Hospital; Neoplasms; Nursing Staff, Hospital; Prospective Studies; Retrospective Studies; Sodium Chloride; Staphylococcal Infections; Vancomycin | 1996 |
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1998 |
Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients.
Topics: Adult; Amikacin; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fever; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Teicoplanin; Vancomycin | 1998 |
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin | 1999 |
An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia.
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Child; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 1999 |
Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis.
Topics: Acute Disease; Aged; Aged, 80 and over; Amikacin; Cataract Extraction; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Female; Glucocorticoids; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2000 |
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure.
Topics: Amikacin; Aminoglycosides; Anti-Infective Agents; Audiometry, Pure-Tone; Auditory Threshold; Diuretics; Ethacrynic Acid; Female; Furosemide; Gentamicins; Hearing Loss, Sensorineural; Humans; Infant, Newborn; Male; Pancuronium; Respiratory Insufficiency; Severity of Illness Index; Tobramycin; Vancomycin; Vecuronium Bromide | 2006 |
Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Blood; Catheterization, Central Venous; Catheters, Indwelling; Ciprofloxacin; Colony Count, Microbial; Cross Infection; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Heparin; Humans; Male; Middle Aged; Vancomycin | 2006 |
Impact of ibuprofen administration on renal drug clearance in the first weeks of life.
Topics: Age Factors; Amikacin; Anti-Bacterial Agents; Aspirin; Betamethasone; Birth Weight; Cyclooxygenase Inhibitors; Double-Blind Method; Ductus Arteriosus, Patent; Female; Glomerular Filtration Rate; Humans; Ibuprofen; Indomethacin; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Kidney; Metabolic Clearance Rate; Postmenopause; Pregnancy; Time Factors; Vancomycin | 2006 |
Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Ceftriaxone; Device Removal; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Kidney Failure, Chronic; Male; Prospective Studies; Renal Dialysis; Treatment Outcome; Vancomycin | 2010 |
Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis.
Topics: Acetylcysteine; Amikacin; Anti-Bacterial Agents; Ear Diseases; Free Radical Scavengers; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Vancomycin | 2011 |
205 other study(ies) available for amikacin and vancomycin
| Article | Year |
|---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Female; Fungi; Male; Mice; Molecular Structure; Rats; Rats, Wistar; Structure-Activity Relationship; Thiadiazoles | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria.
Topics: Anti-Bacterial Agents; Binding Sites; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Enterococcus; Enzyme Inhibitors; Framycetin; Kanamycin Kinase; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs.
Topics: Anthraquinones; Anti-Bacterial Agents; Cations; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization | 2011 |
Synthesis, pharmacological evaluation and docking studies of coumarin derivatives.
Topics: Animals; Coumarins; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Rats; Rats, Wistar; Spectrophotometry, Infrared | 2011 |
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
Topics: Aminoglycosides; Antineoplastic Agents; Base Sequence; DEAD-box RNA Helicases; Humans; MicroRNAs; Models, Biological; Molecular Sequence Data; Ribonuclease III; RNA Processing, Post-Transcriptional | 2012 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Antifungal Amphiphilic Aminoglycosides.
Topics: | 2014 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Synthesis and bioactivity investigation of quinone-based dimeric cationic triazolium amphiphiles selective against resistant fungal and bacterial pathogens.
Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Benzoquinones; Cell Line, Tumor; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Fungal; Humans; Sensitivity and Specificity; Surface-Active Agents; Triazoles | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Bioassay-Guided Isolation of Antibacterial Metabolites from Emericella sp. TJ29.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biological Assay; Emericella; Enterococcus faecalis; Escherichia coli; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Polyketides; Pseudomonas aeruginosa; Terpenes | 2017 |
Bile Acid Oligomers and Their Combination with Antibiotics To Combat Bacterial Infections.
Topics: Anti-Bacterial Agents; Bile Acids and Salts; Drug Interactions; Drug Resistance, Bacterial; Escherichia coli; HEK293 Cells; Humans; Staphylococcus aureus | 2018 |
Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biocompatible Materials; Gram-Negative Bacteria; HEK293 Cells; Humans; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Proteolysis; RAW 264.7 Cells; Spectrometry, Fluorescence | 2019 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
Reisolation and Configurational Reinvestigation of Cottoquinazolines E-G from an Arthropod-Derived Strain of the Fungus
Topics: Alkaloids; Animals; Anti-Bacterial Agents; Arthropods; Aspergillus; Circular Dichroism; Crystallography, X-Ray; Enterococcus faecalis; Fungi; Molecular Structure; Pseudomonas aeruginosa; Quinazolines | 2020 |
Discovery of novel N
Topics: A549 Cells; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cytidine; Drug Discovery; Fungi; Humans; Microbial Sensitivity Tests | 2021 |
Physical compatibility and chemical stability of amikacin sulfate in combination with antibiotics in large-volume parenteral solutions - part III.
Topics: Amikacin; Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Drug Combinations; Drug Incompatibility; Drug Stability; Erythromycin; Injections, Intravenous; Kanamycin; Lincomycin; Novobiocin; Penicillins; Polymyxins; Solutions; Tetracyclines; Time Factors; Vancomycin | 1976 |
Antibiotic-associated colitis: report of a case.
Topics: Amikacin; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Humans; Injections, Intraperitoneal; Kanamycin; Male; Middle Aged; Peritonitis; Vancomycin | 1978 |
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin | 1992 |
Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolones; Roxithromycin; Streptococcus pneumoniae; Streptococcus pyogenes; Vancomycin | 1992 |
[Development of resistance in bacteria interacting with subinhibitory antibiotic concentrations].
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas; Serial Passage; Staphylococcus aureus; Vancomycin | 1992 |
The pH of antibiotic vitreous infusion combinations: a potential cause of retinal toxicity.
Topics: Amikacin; Anti-Bacterial Agents; Buffers; Drug Therapy, Combination; Humans; Hydrogen-Ion Concentration; Methicillin; Ophthalmic Solutions; Retinal Diseases; Therapeutic Irrigation; Tobramycin; Vancomycin; Vitreous Body | 1992 |
Intravitreal antibiotic therapy with vancomycin and aminoglycoside: examination of the retinal toxicity of repetitive injections after vitreous and lens surgery.
Topics: Amikacin; Animals; Drug Therapy, Combination; Fundus Oculi; Gentamicins; Lens, Crystalline; Rabbits; Random Allocation; Retina; Vancomycin; Vitrectomy | 1992 |
Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement.
Topics: Amikacin; Anti-Bacterial Agents; Atmospheric Pressure; Bacteria; Bone Cements; Daptomycin; Dextrans; Diffusion; Methylmethacrylates; Peptides; Porosity; Vancomycin | 1991 |
Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot study.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Hearing; Humans; Male; Middle Aged; Pilot Projects; Vancomycin | 1991 |
In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients.
Topics: Amikacin; Anti-Bacterial Agents; Cephalothin; Gram-Positive Bacteria; Humans; Neoplasms; Spectinomycin; Staphylococcus; Streptococcus; Vancomycin | 1989 |
Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients.
Topics: Amikacin; Creatinine; Drug Administration Schedule; Gentamicins; Humans; Intensive Care Units; Kidney; Monitoring, Physiologic; Tobramycin; Vancomycin | 1989 |
Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates.
Topics: Amikacin; Bacteriophage Typing; Coagulase; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Methicillin; Sepsis; Species Specificity; Staphylococcal Infections; Staphylococcus; Vancomycin | 1989 |
Intravitreal antibiotic therapy with vancomycin and aminoglycoside. An experimental study of combination and repetitive injections.
Topics: Amikacin; Animals; Cornea; Drug Combinations; Gentamicins; Injections; Lens, Crystalline; Photoreceptor Cells; Pigment Epithelium of Eye; Rabbits; Retina; Time Factors; Vancomycin; Vitreous Body | 1989 |
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefsulodin; Clindamycin; Drug Combinations; Drug Synergism; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Naphthyridines; Oxacillin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1987 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Auditory brainstem response in young burn-wound patients treated with ototoxic drugs.
Topics: Adolescent; Amikacin; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Audiometry, Evoked Response; Brain Stem; Burns; Child; Child, Preschool; Female; Gentamicins; Hearing Disorders; Humans; Infant; Male; Vancomycin | 1986 |
Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Amikacin; Animals; Child; Drug Therapy, Combination; Humans; Kanamycin; Kinetics; Meningitis; Methicillin; Nafcillin; Penicillin Resistance; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1985 |
Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Amikacin; Drug Combinations; Female; Humans; Male; Methicillin; Middle Aged; Penicillin Resistance; Sepsis; Staphylococcal Infections; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1985 |
Pirprofen-induced fulminant hepatitis.
Topics: Aged; Alanine Transaminase; Amikacin; Chemical and Drug Induced Liver Injury; Female; Humans; Middle Aged; Phenylpropionates; Rifampin; Spondylitis, Ankylosing; Staphylococcal Infections; Vancomycin | 1985 |
Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci.
Topics: Amikacin; Animals; Endocarditis, Bacterial; Female; Gentamicins; Kanamycin; Penicillins; Rabbits; Streptococcal Infections; Time Factors; Vancomycin | 1985 |
[Intracisternal concentrations of vancomycin and amikacin after lumbar injections].
Topics: Amikacin; Humans; Injections, Spinal; Kanamycin; Male; Middle Aged; Vancomycin | 1983 |
Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.
Topics: Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Drug Combinations; Drug Interactions; Enterococcus faecalis; Imipenem; Microbial Sensitivity Tests; Sisomicin; Streptococcus; Streptomycin; Thienamycins; Vancomycin | 1984 |
The influence of ototoxic drugs on brainstem auditory evoked potentials in man.
Topics: Acoustic Stimulation; Adult; Amikacin; Brain Stem; Cochlear Microphonic Potentials; Evoked Potentials, Auditory; Gentamicins; Hearing Loss, Sensorineural; Humans; Kanamycin; Long-Term Care; Male; Middle Aged; Vancomycin | 1981 |
Systemic prophylaxis of experimental staphylococcal endophthalmitis: comparative efficacy of sparfloxacin, pefloxacin, imipenem, vancomycin, and amikacin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Eye; Eye Infections, Bacterial; Female; Fluoroquinolones; Imipenem; Pefloxacin; Quinolones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
[Treatment of osteomyelitis by local antibiotics using a portable electronic micropump].
Topics: Ambulatory Care; Amikacin; Chronic Disease; Female; Follow-Up Studies; Humans; Infusion Pumps; Injections, Intralesional; Male; Osteomyelitis; Vancomycin | 1994 |
Toxic retinopathy secondary to repeat intravitreal amikacin and vancomycin.
Topics: Amikacin; Child; Endophthalmitis; Eye Injuries, Penetrating; Humans; Male; Retinal Diseases; Vancomycin | 1994 |
Computation of drug concentrations in endocardial vegetations in patients during antibiotic therapy.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Diffusion; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Computer-Assisted; Endocarditis, Bacterial; Female; Humans; Models, Biological; Models, Chemical; Netilmicin; Software; Vancomycin | 1994 |
Activity of glycopeptides in combination with amikacin or rifampin against Staphylococcus epidermidis biofilms on plastic catheters.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Colony Count, Microbial; Drug Therapy, Combination; Humans; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1994 |
In vitro antistaphylococcal activity of collagen-sealed Dacron vascular prostheses bonded with rifampin, vancomycin, or amikacin.
Topics: Amikacin; Blood Vessel Prosthesis; Collagen; Drug Delivery Systems; Immersion; Polyethylene Terephthalates; Prosthesis Design; Rifampin; Staphylococcus aureus; Surface Properties; Time Factors; Vancomycin | 1994 |
A comparative study of enzymuria, in the rat, of the drug combinations amikacin/vancomycin and amikacin/teicoplanin.
Topics: Acetylglucosaminidase; Amikacin; Aminopeptidases; Animals; CD13 Antigens; Drug Therapy, Combination; Injections, Intramuscular; Injections, Intraperitoneal; Kidney; Male; Rats; Rats, Wistar; Teicoplanin; Vancomycin | 1993 |
Neonatal suppurative parotitis: a vanishing disease?
Topics: Amikacin; Cross Infection; Drainage; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Parotitis; Suppuration; Vancomycin | 1993 |
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
Topics: Administration, Topical; Amikacin; Animals; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Male; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits; Vancomycin | 1993 |
Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia.
Topics: Amikacin; Bacteremia; Chromatography, High Pressure Liquid; Drug Synergism; Drug Therapy, Combination; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus; Vancomycin | 1993 |
Measurement of antimicrobial agents in cerebrospinal fluid using the Abbott TDx analyzer.
Topics: Amikacin; Anti-Bacterial Agents; Fluorescence Polarization Immunoassay; Gentamicins; Humans; Tobramycin; Vancomycin | 1993 |
Spontaneous ulcerative keratitis in immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Amikacin; Amphotericin B; Candida albicans; Cefazolin; Ciprofloxacin; Corneal Ulcer; Female; Gentamicins; HIV Seropositivity; Humans; Miconazole; Pseudomonas aeruginosa; Staphylococcus aureus; Substance Abuse, Intravenous; Vancomycin; Visual Acuity | 1993 |
Disseminating infection with Scytalidium dimidiatum in a granulocytopenic child.
Topics: Adolescent; Amikacin; Amphotericin B; Ceftazidime; Drug Therapy, Combination; Humans; Immunocompromised Host; Lymphoma, B-Cell; Male; Mitosporic Fungi; Morocco; Mycoses; Netherlands; Neutropenia; Vancomycin | 1993 |
Hemophagocytic syndrome associated with Bacteroides fragilis infection in a patient with acute monoblastic leukemia.
Topics: Amikacin; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Ceftazidime; Cytarabine; Daunorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Leukemia, Monocytic, Acute; Middle Aged; Moxalactam; Tonsillitis; Vancomycin | 1996 |
[Toxic retinopathy caused by intravitreal injection of amikacin and vancomycin].
Topics: Amikacin; Anti-Bacterial Agents; Corneal Injuries; Drug Therapy, Combination; Eye Injuries, Penetrating; Humans; Injections; Male; Middle Aged; Retinal Diseases; Vancomycin; Vitreous Body | 1996 |
[Clinical, pharmacokinetic and therapeutic study of amikacin with single daily dose and in combination in neutropenic children with fever].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Neutropenia; Penicillins; Piperacillin; Vancomycin | 1996 |
Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells.
Topics: Amikacin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1997 |
Vancomycin and amikacin in cell cultures for virus isolation.
Topics: Age Factors; Amikacin; Animals; Anti-Bacterial Agents; Cell Culture Techniques; Cell Line; Dogs; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Haplorhini; Humans; Microbial Sensitivity Tests; Vancomycin; Virus Cultivation | 1996 |
Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net.
Topics: Amikacin; Anti-Bacterial Agents; Cross Reactions; Fluorescence Polarization Immunoassay; Gentamicins; Humans; Reproducibility of Results; Tobramycin; Vancomycin | 1997 |
Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.
Topics: Amikacin; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fusidic Acid; Logistic Models; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Vancomycin | 1997 |
Does vancomycine increase aminoglycoside nephrotoxicity?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Interactions; Drug Therapy, Combination; Kidney; Rats; Rats, Wistar; Vancomycin | 1997 |
Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Injuries, Penetrating; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Care; Prospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin; Visual Acuity | 1997 |
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; beta-Lactamases; Child; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillin Resistance; Penicillins; Streptomycin; Urinary Tract Infections; Vancomycin | 1998 |
[Vancomycin-resistant enterococci in pediatric hematology: don't panic!].
Topics: Amikacin; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Transplantation; Carrier State; Catheterization, Central Venous; Child; Decontamination; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Equipment Contamination; Feces; France; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Home Nursing; Hospitalization; Humans; Hygiene; Imipenem; Immunocompromised Host; Mouth; Mouthwashes; Piperacillin; Premedication; Prospective Studies; Transplantation Conditioning; Vancomycin | 1998 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
[Sepsis caused by Streptococcus pneumonia in newborn infants. 2 case reports].
Topics: Age Factors; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Humans; Infant, Newborn; Male; Netilmicin; Penicillins; Pneumonia, Pneumococcal; Radiography, Thoracic; Time Factors; Vancomycin | 1998 |
Difficulties in the assay of liposomal amikacin (MiKasome) in serum.
Topics: Amikacin; Anti-Bacterial Agents; Drug Carriers; Fluoroimmunoassay; Gentamicins; Hot Temperature; Humans; Liposomes; Reagent Kits, Diagnostic; Surface-Active Agents; Vancomycin | 1999 |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Culture Media; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Keratitis; Male; Middle Aged; Propionibacterium acnes; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1999 |
Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods.
Topics: Algorithms; Amikacin; Animals; Anti-Bacterial Agents; Bayes Theorem; Computer Simulation; Humans; Models, Biological; Models, Statistical; Nonlinear Dynamics; Pharmacokinetics; Statistics, Nonparametric; Vancomycin | 2000 |
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin | 2000 |
A case of costochondral abscess due to Corynebacterium minutissimum in an HIV-infected patient.
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Infections; HIV-1; Humans; Male; Penicillins; Ribs; Rifampin; Tomography, X-Ray Computed; Vancomycin | 2000 |
Pharmacokinetic longitudinal studies of antibiotics administered via a permanent intraosseous device in micropigs.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Area Under Curve; Catheters, Indwelling; Infusions, Intraosseous; Longitudinal Studies; Swine; Vancomycin | 2001 |
Translimbal approach for intravitreal injection in endophthalmitis after phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anesthesia, Local; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Injections; Limbus Corneae; Male; Phacoemulsification; Pseudomonas Infections; Vancomycin; Vitreous Body | 2001 |
Antibiotic susceptibility and phage typing of methicillin-resistant and -sensitive Staphylococcus aureus clinical isolates at three periods during 1991-1997.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriophage Typing; Cross Infection; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
Intravitreal antibiotics: the emergency kit.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Vancomycin; Vitreous Body | 2001 |
Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefepime; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Female; Fever; Hospitals, Teaching; Humans; Male; Middle Aged; Neutropenia; Oxacillin; Practice Guidelines as Topic; Teicoplanin; Treatment Outcome; Vancomycin | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
[Nosocomial catheter-related sepsis secondary to central venous catheters].
Topics: Amikacin; Anti-Bacterial Agents; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1999 |
[Obesity, diabetes mellitus, and gas gangrene: a major therapeutic challenge].
Topics: Abscess; Amikacin; Anus Diseases; Buttocks; Candidiasis; Ceftazidime; Colostomy; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Fasciitis; Female; Gas Gangrene; Humans; Hyperbaric Oxygenation; Hypertension; Metronidazole; Middle Aged; Obesity, Morbid; Postoperative Complications; Shock, Septic; Vancomycin | 2001 |
Large atrial septal aneurysm and delayed improvement of renal failure due to nephrotoxic drugs (and hemodialysis) in a diabetic patient.
Topics: Acute Kidney Injury; Amikacin; Anti-Bacterial Agents; Coronary Aneurysm; Diabetes Complications; Diabetes Mellitus; Endocarditis; Female; Heart Septal Defects, Atrial; Humans; Middle Aged; Time Factors; Ultrasonography; Vancomycin | 2002 |
Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Chicago; Enterococcus; Female; Hematology; Humans; Intensive Care Units; Length of Stay; Male; Medical Oncology; Middle Aged; Prospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2002 |
Multiple embolism in a female patient with infective endocarditis. Low back pain and hematuria as the initial clinical manifestations.
Topics: Amikacin; Ceftriaxone; Cephalosporins; Embolism; Endocarditis, Bacterial; Female; Hematuria; Humans; Low Back Pain; Middle Aged; Mitral Valve Prolapse; Streptococcus; Vancomycin | 2002 |
Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber.
Topics: Amikacin; Anti-Bacterial Agents; Drug Carriers; Drug Delivery Systems; Gentamicins; Humans; In Vitro Techniques; Models, Immunological; Osteomyelitis; Polymethyl Methacrylate; Reproducibility of Results; Time Factors; Tobramycin; Vancomycin; Vasodilator Agents | 2002 |
Endophthalmitis.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Aqueous Humor; Bacteria; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Vancomycin; Vitrectomy; Vitreous Body | 2002 |
Effect of analytical inaccuracy on dose adjustment for vancomycin, amikacin, and tobramycin using the Abbottbase Pharmacokinetic Systems.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Monitoring; Female; Fluorescence Polarization Immunoassay; Humans; Male; Middle Aged; Pharmacokinetics; Tobramycin; Vancomycin | 2002 |
[Endophthalmitis following cataract surgery].
Topics: Amikacin; Cefotaxime; Ceftazidime; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Follow-Up Studies; Humans; Infusions, Intravenous; Lenses, Intraocular; Postoperative Complications; Prosthesis-Related Infections; Recurrence; Reoperation; Retrospective Studies; Staphylococcal Infections; Vancomycin; Visual Acuity; Vitrectomy | 2002 |
Rhodococcus globerulus keratitis after laser in situ keratomileusis.
Topics: Actinomycetales Infections; Adult; Amikacin; Corneal Stroma; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Keratomileusis, Laser In Situ; Rhodococcus; Surgical Flaps; Vancomycin | 2002 |
Aminoglycoside nephrotoxicity: modeling, simulation, and control.
Topics: Adult; Algorithms; Amikacin; Anti-Bacterial Agents; Area Under Curve; Circadian Rhythm; Computer Simulation; Creatinine; Female; Humans; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Male; Models, Biological; Vancomycin | 2003 |
Endogenous endophthalmitis after routine dental cleaning.
Topics: Amikacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Middle Aged; Oral Hygiene; Streptococcal Infections; Streptococcus; Vancomycin; Vitrectomy; Vitreous Body | 2003 |
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis.
Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Aminoglycoside and vancomycin serum concentration monitoring and mortality due to neonatal sepsis in Saudi Arabia.
Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Humans; Incidence; Infant, Newborn; Retrospective Studies; Saudi Arabia; Sepsis; Vancomycin | 2003 |
[Characteristics of bacteriology and drug sensitivity in patients with COPD combined with pneumonia].
Topics: Adult; Aged; Amikacin; Bacteria; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Vancomycin | 2003 |
Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.
Topics: Amikacin; Animals; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Imipenem; Injections, Intravenous; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2004 |
[Endogenous bacterial endophthalmitis: a retrospective study on 22 consecutive cases].
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Causality; Combined Modality Therapy; Endophthalmitis; Eye Enucleation; Female; Gentamicins; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Analysis; Vancomycin; Vitrectomy; Vitreous Body | 2004 |
[Investigation on the drug resistance of Pseudomonas aeruginosa in our burn ward in the past 11 years].
Topics: Amikacin; Anti-Bacterial Agents; Burn Units; Ceftazidime; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Imipenem; Penicillins; Pseudomonas aeruginosa; Vancomycin | 2004 |
Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Adhesion; Biofilms; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Escherichia coli; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Netilmicin; Predictive Value of Tests; Pseudomonas aeruginosa; Staphylococcus; Teicoplanin; Tetracycline; Vancomycin | 2004 |
Treatment of vancomycin-intermediate Staphylcoccus aureus endocarditis with linezolid.
Topics: Acetamides; Amikacin; Anti-Infective Agents; Aortic Valve; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2004 |
Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cloxacillin; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospitals, University; Humans; Imipenem; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pakistan; Retrospective Studies; Vancomycin | 2004 |
Evaluation of the neutralising capacity of bactec medium for some antibiotics.
Topics: Amikacin; Amoxicillin; Amphotericin B; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Culture Media; Gentamicins; Penicillins; Vancomycin | 2004 |
Staphylococcus hominis endophthalmitis associated with a capsular hypopyon.
Topics: Amikacin; Chronic Disease; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Staphylococcal Infections; Staphylococcus hominis; Suppuration; Vancomycin; Vitreous Body | 2005 |
Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Equipment Contamination; Gentamicins; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Mycobacterium; Mycobacterium Infections; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pneumonia, Pneumocystis; Renal Dialysis; Rifabutin; Vancomycin | 2005 |
Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Female; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Vancomycin | 2005 |
The fixed combination of fortified vancomycin and amikacin ophthalmic solution--VA solution: in vitro study of the potency and stability.
Topics: Amikacin; Anti-Bacterial Agents; Colony Count, Microbial; Drug Combinations; Drug Stability; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Ophthalmic Solutions; Osmolar Concentration; Pseudomonas aeruginosa; Staphylococcus epidermidis; Streptococcus pneumoniae; Vancomycin | 2005 |
Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fluoroquinolones; Gammaproteobacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Population Surveillance; Vancomycin; Vancomycin Resistance | 2006 |
An in vitro study on the compatibility and concentrations of combinations of vancomycin, amikacin, and dexamethasone in human vitreous.
Topics: Amikacin; Anti-Bacterial Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; Dexamethasone; Dialysis; Drug Interactions; Drug Stability; Drug Therapy, Combination; Fluorescence Polarization Immunoassay; Glucocorticoids; Humans; In Vitro Techniques; Vancomycin; Vitreous Body | 2007 |
Presumed macular toxicity of intravitreal antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Eye Foreign Bodies; Humans; Injections; Macula Lutea; Retinal Diseases; Surgical Wound Infection; Vancomycin; Vitreous Body | 2006 |
Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Creatinine; Cystatin C; Cystatins; Drug Monitoring; Female; Gentamicins; Glomerular Filtration Rate; Hepatic Insufficiency; Humans; Male; Metabolic Clearance Rate; Middle Aged; Tobramycin; Vancomycin | 2006 |
A simplified method of antibiotic lock therapy for Broviac-Hickman catheters using a CLC 2000 connector device.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Corynebacterium Infections; Female; Humans; Infant; Male; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 2007 |
Prolonged unconsciousness in a patient with End-stage Renal Disease.
Topics: Aged; Amikacin; Brain Abscess; Brain Diseases; Brain Edema; Ceftriaxone; Humans; Kidney Failure, Chronic; Male; Nocardia Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Unconsciousness; Vancomycin | 2006 |
In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cephalothin; Dicloxacillin; Drug Synergism; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 2006 |
Amniotic membrane transplantation in severe bacterial keratitis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Amnion; Anti-Bacterial Agents; Ceftazidime; Combined Modality Therapy; Corneal Ulcer; Drug Therapy, Combination; Epithelium, Corneal; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Male; Middle Aged; Pain Measurement; Prospective Studies; Vancomycin; Wound Healing | 2007 |
Renal drug clearance in preterm neonates: relation to prenatal growth.
Topics: Amikacin; Anti-Bacterial Agents; Drug Monitoring; Fetal Growth Retardation; Glomerular Filtration Rate; Humans; Infant, Newborn; Infant, Premature; Metabolic Clearance Rate; Vancomycin | 2007 |
[Distortion product otoacoustic emissions in newborns treated by ototoxic drugs].
Topics: Amikacin; Aminoglycosides; Cochlear Diseases; Follow-Up Studies; Hearing Loss, Sensorineural; Humans; Infant, Newborn; Otitis Media; Otoacoustic Emissions, Spontaneous; Prospective Studies; Severity of Illness Index; Vancomycin | 2007 |
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
[Fortified antibiotic (vancomycin, amikacin and ceftazidime) eye drop stability assessment at -20 degrees C].
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Stability; Freezing; Ophthalmic Solutions; Vancomycin | 2007 |
Comparison of topical fixed-combination fortified vancomycin-amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Child; Corneal Ulcer; Drug Combinations; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin; Young Adult | 2009 |
Endophthalmitis caused by Bacillus species.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacillus; Cephalosporins; Child; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 2008 |
Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Imipenem; Injections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2008 |
Incidence of endophthalmitis following vitreoretinal surgery.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Female; Gentamicins; Humans; Male; Middle Aged; Postoperative Complications; United Kingdom; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2009 |
Treatment of postcataract extraction endophthalmitis: a summary of the results from the Endophthalmitis Vitrectomy Study.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Lens Implantation, Intraocular; Male; Multicenter Studies as Topic; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2008 |
Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Burns; Exudates and Transudates; Female; Humans; Male; Middle Aged; Prospective Studies; Vancomycin; Young Adult | 2009 |
In vitro elution of vancomycin/amikacin/steroid from solvent-free biodegradable scleral plugs.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Drug Stability; Drug Therapy, Combination; Endophthalmitis; Escherichia coli; Glucocorticoids; Lactic Acid; Microbial Sensitivity Tests; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sclera; Staphylococcus aureus; Vancomycin | 2009 |
Traumatic endophthalmitis caused by Enterococcus raffinosus and Enterobacter gergoviae.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Endophthalmitis; Enterobacter; Enterobacteriaceae Infections; Enterococcus; Eye Injuries, Penetrating; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin; Wound Infection | 2009 |
Listeria monocytogenes meningitis in two immunocompetent children.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Immunocompetence; Infant; Listeriosis; Male; Meningitis, Listeria; Meropenem; Risk Factors; Spinal Puncture; Thienamycins; Vancomycin | 2009 |
The impact of ibuprofen or indomethacin on renal drug clearance in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Cyclooxygenase Inhibitors; Drug Interactions; Glomerular Filtration Rate; Humans; Ibuprofen; Indomethacin; Infant, Newborn; Kidney; Metabolic Clearance Rate; Vancomycin | 2009 |
Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biocompatible Materials; Dexamethasone; Drug Carriers; Drug Delivery Systems; Endophthalmitis; Lactic Acid; Materials Testing; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Rabbits; Sclera; Solvents; Vancomycin | 2010 |
Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Audiometry, Pure-Tone; Case-Control Studies; Cephalothin; Female; Hearing Loss; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Regression Analysis; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Vancomycin | 2010 |
Chitosan sponges to locally deliver amikacin and vancomycin: a pilot in vitro evaluation.
Topics: Amikacin; Anti-Bacterial Agents; Biocompatible Materials; Chitosan; Drug Carriers; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2010 |
In vitro stability of fortified ophthalmic antibiotics stored at -20 degrees C for 6 months.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cryopreservation; Drug Stability; Drug Storage; Microbial Sensitivity Tests; Ophthalmic Solutions; Time Factors; Vancomycin | 2010 |
MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Humans; Microscopy, Electron, Scanning; Staphylococcus epidermidis; Vancomycin | 2010 |
Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carboplatin; Cisplatin; Cross-Sectional Studies; Female; Gentamicins; Hearing Tests; Humans; Incidence; Male; Middle Aged; Neoplasms; Prospective Studies; Risk; Time Factors; Tinnitus; Tobramycin; Vancomycin; Veterans | 2010 |
In vitro elution of amikacin and vancomycin from impregnated plaster of Paris beads.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microspheres; Staphylococcal Infections; Vancomycin | 2010 |
Local antibiotic delivery using tailorable chitosan sponges: the future of infection control?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Infections; Biocompatible Materials; Chitosan; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Fractures, Open; Goats; Infection Control; Pseudomonas Infections; Staphylococcal Infections; Vancomycin | 2010 |
Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Female; Gastroscopy; Gynecological Examination; Humans; Imipenem; Middle Aged; Peritoneal Dialysis; Peritonitis; Secondary Prevention; Treatment Outcome; Vancomycin | 2010 |
Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheters, Indwelling; Gram-Negative Bacterial Infections; Humans; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Teicoplanin; Time Factors; Vancomycin | 2011 |
Burkholderia cepacia endophthalmitis: clinico-microbiologic profile and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Child; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Retrospective Studies; Treatment Outcome; Vancomycin; Visual Acuity | 2011 |
Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain.
Topics: Adult; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Clostridioides difficile; Clostridium Infections; Comorbidity; Humans; Male; Ohio; Treatment Outcome; Vancomycin | 2011 |
Infectious scleritis after subtenon triamcinolone acetonide injection.
Topics: Administration, Topical; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Corneal Transplantation; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Injections, Intraocular; Male; Necrosis; Ophthalmic Solutions; Scleritis; Staphylococcal Infections; Staphylococcus epidermidis; Tenon Capsule; Triamcinolone Acetonide; Vancomycin; Young Adult | 2011 |
In vitro elution and antibacterial activity of clindamycin, amikacin, and vancomycin from R-gel polymer.
Topics: Absorbable Implants; Amikacin; Anti-Bacterial Agents; Clindamycin; Polymers; Staphylococcus aureus; Time Factors; Vancomycin | 2011 |
Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nomograms; Teicoplanin; Vancomycin; Young Adult | 2011 |
Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Topics: Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefazolin; Ceftazidime; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Enterococcus; Female; Humans; Male; Middle Aged; Multivariate Analysis; Oxacillin; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2012 |
Elution of antimicrobials from a cross-linked dextran gel: In vivo quantification.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Area Under Curve; Clindamycin; Delayed-Action Preparations; Dextrans; Drug Implants; Horses; Microbial Sensitivity Tests; Vancomycin | 2013 |
From penicillin-streptomycin to amikacin-vancomycin: antibiotic decontamination of cardiovascular homografts in Singapore.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Blood Vessel Prosthesis; Decontamination; Humans; Microbial Sensitivity Tests; Penicillins; Singapore; Streptomycin; Temperature; Time Factors; Transplantation, Homologous; Vancomycin | 2012 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
Early vancomycin, amikacin and gentamicin concentrations in pulmonary artery and pulmonary tissue are not affected by VA ECMO (venoarterial extracorporeal membrane oxygenation) in a pig model of prolonged cardiac arrest.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Extracorporeal Membrane Oxygenation; Female; Gentamicins; Heart Arrest; Lung; Pulmonary Artery; Swine; Time Factors; Tissue Distribution; Vancomycin | 2013 |
High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Catheters; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Male; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Failure; Vancomycin | 2013 |
Chitosan sponges for local synergistic infection therapy: a pilot study.
Topics: Amikacin; Anti-Infective Agents; Chitosan; Daptomycin; Drug Delivery Systems; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pilot Projects; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Changing profile of organisms causing scleral buckle infections: a clinico-microbiological case series.
Topics: Adolescent; Adult; Aged; Amikacin; Bacteria; Device Removal; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prosthesis-Related Infections; Retinal Detachment; Retrospective Studies; Scleral Buckling; Vancomycin | 2014 |
Mechanical strength and in vitro antibiotic release profile of antibiotic-loaded calcium phosphate bone cement.
Topics: Amikacin; Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Compressive Strength; Delayed-Action Preparations; Drug Carriers; Feasibility Studies; Hardness; Humans; Materials Testing; Stress, Mechanical; Time Factors; Vancomycin; Viscosity | 2013 |
Amikacin population pharmacokinetics among paediatric burn patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Body Surface Area; Body Weight; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Multivariate Analysis; Regression Analysis; Sepsis; Vancomycin | 2014 |
Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Female; Glomerular Filtration Rate; Humans; Infant; Infant, Newborn; Kidney; Male; Models, Biological; Vancomycin | 2013 |
The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
Topics: Administration, Topical; Aged; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Case-Control Studies; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Intravitreal Injections; Male; Middle Aged; Ophthalmic Solutions; Retinal Diseases; Retrospective Studies; Vancomycin; Visual Acuity; Vitreous Body | 2014 |
Antibiogram pattern of oral microflora in periodontic children of age group 6 to 12 years: a clinicomicrobiological study.
Topics: Aggregatibacter actinomycetemcomitans; Amikacin; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacterial Load; Bacteriological Techniques; Child; Clindamycin; Dental Caries; Enterococcus faecalis; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Mouth; Porphyromonas gingivalis; Streptococcus mutans; Tetracycline; Vancomycin | 2013 |
Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Combined Modality Therapy; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Treatment Outcome; Vancomycin; Viridans Streptococci; Visual Acuity; Vitrectomy; Young Adult | 2014 |
Development of a Fourier transform infrared spectroscopy coupled to UV-Visible analysis technique for aminosides and glycopeptides quantitation in antibiotic locks.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Calibration; Catheter-Related Infections; Catheters; Chromatography, High Pressure Liquid; Gentamicins; Glycopeptides; Molecular Structure; Reference Values; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Sterilization; Syringes; Teicoplanin; Vancomycin | 2014 |
A simple quantitative method analysing amikacin, gentamicin, and vancomycin levels in human newborn plasma using ion-pair liquid chromatography/tandem mass spectrometry and its applicability to a clinical study.
Topics: Amikacin; Chromatography, Liquid; Drug Stability; Gentamicins; Humans; Infant, Newborn; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Vancomycin | 2014 |
Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Aqueous Humor; Bacteria; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; United Kingdom; Vancomycin; Visual Acuity; Vitreous Body | 2014 |
Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-β-lactamase-producing Klebsiella oxytoca.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Coinfection; Fosfomycin; Humans; Klebsiella Infections; Klebsiella oxytoca; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2015 |
Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Coated Materials, Biocompatible; Drug Carriers; Mice; Point-of-Care Systems; Prostheses and Implants; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 2015 |
In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.
Topics: Amikacin; Anti-Infective Agents; Arginine; Bacteria; Biofilms; Catheter-Related Infections; Chelating Agents; Colony Count, Microbial; Disinfection; Edetic Acid; Gentamicins; Humans; Microbial Viability; Vancomycin | 2015 |
Successful reimplantation of extruded long bone segments in open fractures of lower limb--a report of 3 cases.
Topics: Accidents, Traffic; Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefuroxime; Debridement; Femoral Fractures; Fracture Healing; Fractures, Open; Humans; India; Male; Middle Aged; Replantation; Tibial Fractures; Treatment Outcome; Vancomycin | 2015 |
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Topics: Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Japan; Klebsiella oxytoca; Klebsiella pneumoniae; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections; Vancomycin | 2015 |
MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Bacteria; Ceftazidime; Drug Combinations; Drug Substitution; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Vancomycin; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Body | 2016 |
[Low grade endophthalmitis caused by P. acnes : Case report].
Topics: Aged, 80 and over; Amikacin; Combined Modality Therapy; Diagnosis, Differential; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Lenses, Intraocular; Postoperative Complications; Propionibacterium acnes; Vancomycin; Vitrectomy | 2016 |
Polymicrobial Biofilm Inhibition Effects of Acetate-Buffered Chitosan Sponge Delivery Device.
Topics: Acetates; Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Catheter-Related Infections; Catheters; Chitosan; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Drug Liberation; Freeze Drying; Humans; Mice; Polytetrafluoroethylene; Pseudomonas aeruginosa; Skin; Staphylococcus aureus; Vancomycin | 2016 |
Pre-packing of cost effective antibiotic cement beads for the treatment of traumatic osteomyelitis in the developing world - an in-vitro study based in Cambodia.
Topics: Amikacin; Anti-Bacterial Agents; Bone Cements; Cambodia; Ceftriaxone; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Delivery Systems; Drug Stability; Fractures, Open; Gentamicins; Humans; Microspheres; Osteomyelitis; Polymethyl Methacrylate; Vancomycin | 2016 |
Persistently Vitreous Culture-Positive Exogenous Bacterial Endophthalmitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteria; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Glaucoma; Humans; Intravitreal Injections; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2016 |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters, Indwelling; Cross Infection; Cystectomy; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospital Units; Humans; Immunosuppression Therapy; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Surgical Wound Infection; Urinary Catheters; Urinary Tract Infections; Urology; Vancomycin | 2017 |
Facilitate Treatment Adjustment After Overdosing: Another Step Toward 21st-Century Medicine.
Topics: Amikacin; Anti-Bacterial Agents; Drug Overdose; Humans; Infant; Infant, Newborn; Kidney; Male; Medication Errors; Models, Biological; Pharmaceutical Preparations; Renal Insufficiency; Vancomycin | 2017 |
Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit.
Topics: Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Central Nervous System Infections; Colistin; Humans; Injections, Intraventricular; Injections, Spinal; Intensive Care Units; Neurosurgical Procedures; Retrospective Studies; Vancomycin | 2017 |
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.
Topics: Adolescent; Adult; Age Factors; Amikacin; Anti-Bacterial Agents; Audiometry, Pure-Tone; Bacterial Infections; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Patient Outcome Assessment; Sex Factors; Time; Tobramycin; United States; Vancomycin | 2017 |
Effect of Successive Administration of Vancomycin and Amikacin on Auditory Function of Immature Animals.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Evoked Potentials, Auditory, Brain Stem; Hair Cells, Auditory, Outer; Otoacoustic Emissions, Spontaneous; Rabbits; Time Factors; Vancomycin; Weight Gain | 2017 |
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin | 2017 |
Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bile Acids and Salts; Biofilms; Chick Embryo; Humans; Kanamycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2017 |
Improvement of an In Vitro Model to Assess Delivered Dose and Particle Size for a Vibrating Mesh Nebulizer During Mechanical Ventilation.
Topics: Administration, Inhalation; Aerosols; Amikacin; Anti-Bacterial Agents; Drug Delivery Systems; Equipment Design; Humans; Humidity; Intubation, Intratracheal; Models, Biological; Nebulizers and Vaporizers; Particle Size; Respiration, Artificial; Vancomycin; Vibration | 2018 |
Local Delivery of Amikacin and Vancomycin from Chitosan Sponges Prevent Polymicrobial Implant-Associated Biofilm.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Chitosan; Coinfection; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Vancomycin | 2018 |
The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Topics: Acinetobacter baumannii; Amikacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Levofloxacin; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus pneumoniae; Tigecycline; Vancomycin | 2018 |
Neuroendoscopic Evaluation and Treatment for Cerebral Ventricular Infection.
Topics: Administration, Intravenous; Adult; Amikacin; Anti-Bacterial Agents; Brain Diseases; Cerebral Ventricles; Female; Gentamicins; Humans; Male; Middle Aged; Neuroendoscopy; Neurosurgical Procedures; Treatment Outcome; Vancomycin | 2018 |
Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Load; Biofilms; Drug Combinations; Drug Therapy, Combination; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus; Time Factors; Vancomycin | 2019 |
Characterization of trimethyl chitosan/polyethylene glycol derivatized chitosan blend as an injectable and degradable antimicrobial delivery system.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Chitosan; Drug Carriers; Injections; Materials Testing; Mice; Muramidase; NIH 3T3 Cells; Polyethylene Glycols; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin; Viscosity | 2019 |
Ready for TDM: Simultaneous quantification of amikacin, vancomycin and creatinine in human plasma employing ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, Liquid; Creatinine; Drug Monitoring; Humans; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry; Vancomycin | 2019 |
A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Monitoring; Female; Gentamicins; Hospitals, Pediatric; Humans; Infant; Male; Retrospective Studies; Vancomycin | 2020 |
Characterization and Antibiofilm Activity of Mannitol-Chitosan-Blended Paste for Local Antibiotic Delivery System.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Chitosan; Drug Carriers; Drug Delivery Systems; Inflammation; Mannitol; Microbial Sensitivity Tests; Polyethylene Glycols; Staphylococcus aureus; Vancomycin | 2019 |
Arcuate keratotomy infiltration following uneventful femtosecond laser assisted cataract surgery.
Topics: Administration, Topical; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cataract Extraction; Cornea; Corneal Topography; Eye Infections, Bacterial; Humans; Keratitis; Keratoplasty, Penetrating; Laser Therapy; Male; Ophthalmic Solutions; Refraction, Ocular; Reoperation; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Vancomycin; Visual Acuity | 2019 |
Analytical validation of a quantitative method for therapeutic drug monitoring on the Alinity
Topics: Amikacin; Automation, Laboratory; Colorimetry; Drug Monitoring; Gentamicins; Humans; Immunoassay; Nephelometry and Turbidimetry; Phenobarbital; Phenytoin; Reproducibility of Results; Theophylline; Valproic Acid; Vancomycin | 2020 |
Amikacin initial dosage in patients with hypoalbuminaemia: an interactive tool based on a population pharmacokinetic approach.
Topics: Amikacin; Anti-Bacterial Agents; Glomerular Filtration Rate; Humans; Hypoalbuminemia; Models, Biological; Vancomycin | 2020 |
Amikacin or Vancomycin Exposure Alters the Postnatal Serum Creatinine Dynamics in Extreme Low Birth Weight Neonates.
Topics: Amikacin; Anti-Bacterial Agents; Child; Creatinine; Humans; Infant, Low Birth Weight; Infant, Newborn; Vancomycin | 2021 |
Identifying alternative antibiotics that elute from calcium sulfate beads for treatment of orthopedic infections.
Topics: Amikacin; Anti-Bacterial Agents; Calcium Sulfate; Cefazolin; Meropenem; Minocycline; Tobramycin; Vancomycin | 2022 |
To Estimate or to Forecast? Lessons From a Comparative Analysis of Four Bayesian Fitting Methods Based on Nonparametric Models.
Topics: Aged; Amikacin; Bayes Theorem; Drug Monitoring; Humans; Software; Vancomycin | 2021 |
Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ceftazidime; Drug Resistance, Multiple, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2021 |
[Impact of the vancomycin and amikacin therapeutic monitoring in the optimization of antimicrobial dose in pediatric patients].
Topics: Amikacin; Anti-Bacterial Agents; Child; Drug Monitoring; Humans; Infant, Newborn; Pediatrics; Retrospective Studies; Vancomycin | 2021 |
Biomarkers in neonates receiving potential nephrotoxic drugs.
Topics: Acetaminophen; Adult; Amikacin; Biomarkers; Cystatins; Female; Furosemide; Gentamicins; Hepatitis A Virus Cellular Receptor 1; Humans; Ibuprofen; Infant, Newborn; Kidney Diseases; Lipocalin-2; Male; Middle Aged; Vancomycin | 2021 |
The evaluation of antibiotic susceptibility pattern and associated risk factors of UTI in tertiary care hospital of Peshawar.
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli; Female; Fosfomycin; Humans; Imipenem; Klebsiella pneumoniae; Linezolid; Male; Meropenem; Pseudomonas aeruginosa; Risk Factors; Tertiary Care Centers; Urinary Tract Infections; Vancomycin | 2022 |
Antibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Staphylococcus aureus; Vancomycin | 2022 |
Molecular Detection of
Topics: Amikacin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Erythromycin; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Vancomycin | 2022 |
Frequency and Antibiotic Susceptibility Pattern of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) in Uncomplicated Skin and Soft Tissue Infections.
Topics: Agar; Amikacin; Animals; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Female; Furunculosis; Humans; Impetigo; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin | 2022 |
A 12-Year Retrospective Analysis of Blood Culture Isolates in the Intensive Care Unit of a Tertiary Hospital in China.
Topics: Amikacin; Anti-Bacterial Agents; Blood Culture; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Intensive Care Units; Linezolid; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Sepsis; Teicoplanin; Tertiary Care Centers; Vancomycin | 2023 |